Literature DB >> 19104146

Revisiting Notch in remyelination of multiple sclerosis lesions.

Celia F Brosnan1, Gareth R John.   

Abstract

MS results from destruction of the protective myelin sheath surrounding axons, which prevents the transmission of nerve impulses. Precursors of oligodendrocytes, the cells capable of myelinating axons, are preserved in demyelinating lesions; however, why these precursors do not differentiate into mature oligodendrocytes and remyelinate axons is unknown. Contactin is a noncanonical Notch receptor ligand that mediates oligodendrocyte differentiation. In this issue of the JCI, Nakahara et al. show that Contactin is abundantly expressed on demyelinated axons in human chronic MS lesions and that Notch1 is activated in oligodendrocyte precursor cells (see the related article beginning on page 169). However, Notch1 intracellular domain coassociates with the nuclear transporter Importin beta but fails to show evidence of nuclear translocation. These cytoplasmic aggregates also contain TAT-interacting protein 30 kDa (TIP30), a proapoptotic factor, which inhibits nuclear transport and, consequently, Notch1-mediated oligodendrocyte differentiation and remyelination. These data target TIP30 as a new pathogenic factor in MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19104146      PMCID: PMC2613471          DOI: 10.1172/JCI37786

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation.

Authors:  Qi-Dong Hu; Beng-Ti Ang; Meliha Karsak; Wei-Ping Hu; Xiao-Ying Cui; Tanya Duka; Yasuo Takeda; Wendy Chia; Natesan Sankar; Yee-Kong Ng; Eng-Ang Ling; Thomas Maciag; Deena Small; Radianna Trifonova; Raphael Kopan; Hideyuki Okano; Masato Nakafuku; Shigeru Chiba; Hisamaru Hirai; Jon C Aster; Melitta Schachner; Catherine J Pallen; Kazutada Watanabe; Zhi-Cheng Xiao
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

2.  Notch signaling: a rheostat regulating oligodendrocyte differentiation?

Authors:  Brian Popko
Journal:  Dev Cell       Date:  2003-11       Impact factor: 12.270

3.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.

Authors:  Christopher Lock; Guy Hermans; Rosetta Pedotti; Andrea Brendolan; Eric Schadt; Hideki Garren; Annette Langer-Gould; Samuel Strober; Barbara Cannella; John Allard; Paul Klonowski; Angela Austin; Nagin Lad; Naftali Kaminski; Stephen J Galli; Jorge R Oksenberg; Cedric S Raine; Renu Heller; Lawrence Steinman
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

4.  Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination.

Authors:  J C Rios; C V Melendez-Vasquez; S Einheber; M Lustig; M Grumet; J Hemperly; E Peles; J L Salzer
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

5.  Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.

Authors:  Mark F Stidworthy; Stephane Genoud; Wen-Wu Li; Dino P Leone; Ned Mantei; Ueli Suter; Robin J M Franklin
Journal:  Brain       Date:  2004-08-02       Impact factor: 13.501

6.  Inhibition of nuclear import by the proapoptotic protein CC3.

Authors:  Frank W King; Emma Shtivelman
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation.

Authors:  Gareth R John; Sai Latha Shankar; Bridget Shafit-Zagardo; Aldo Massimi; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  Nat Med       Date:  2002-09-23       Impact factor: 53.440

8.  Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.

Authors:  Guus Wolswijk; Rawien Balesar
Journal:  Brain       Date:  2003-04-22       Impact factor: 13.501

9.  Sequence of contactin, a 130-kD glycoprotein concentrated in areas of interneuronal contact, defines a new member of the immunoglobulin supergene family in the nervous system.

Authors:  B Ranscht
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

10.  Notch1 control of oligodendrocyte differentiation in the spinal cord.

Authors:  Stephane Genoud; Corinna Lappe-Siefke; Sandra Goebbels; Freddy Radtke; Michel Aguet; Steven S Scherer; Ueli Suter; Klaus-Armin Nave; Ned Mantei
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

View more
  14 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 2.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 3.  An overview of notch signaling in adult tissue renewal and maintenance.

Authors:  Chihiro Sato; Guojun Zhao; Ma Xenia G Ilagan
Journal:  Curr Alzheimer Res       Date:  2012-02       Impact factor: 3.498

4.  Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury.

Authors:  Ahdeah Pajoohesh-Ganji; Mark P Burns; Sonali Pal-Ghosh; Gauri Tadvalkar; Nicole G Hokenbury; Mary Ann Stepp; Alan I Faden
Journal:  Brain Res       Date:  2014-03-11       Impact factor: 3.252

Review 5.  Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

Authors:  Reshmi Tognatta; Robert H Miller
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

Review 6.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 7.  Targeting oligodendrocyte protection and remyelination in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Sean Mahase; Dipankar J Dutta; Virginie Bonnamain; Azeb T Argaw; Gareth R John
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 8.  Mediators of oligodendrocyte differentiation during remyelination.

Authors:  Jigisha R Patel; Robyn S Klein
Journal:  FEBS Lett       Date:  2011-04-29       Impact factor: 4.124

Review 9.  Remyelination therapy for multiple sclerosis.

Authors:  Michael B Keough; V Wee Yong
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

10.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.